SHCBP1 and neoplasm: These data demonstrated that targeting SHCBP1 in tumour cells abrogated WEE1-phosphorylated cdc2 (Tyr15) axis-mediated maintenance of the G2–M checkpoint, which is responsible for the premature mitotic entry with unrepaired DNA damage.